COMPOSITION FOR USE IN THE PREVENTION OF SEVERE FORMS OF VIRAL INFECTIONS DUE TO BETACORONAVIRUS

The present invention concerns a composition comprising an Angiotensin receptor 1 (AT1) inhibitor and one or more other active compounds selected from the group consisting of antioxidants, caspase inhibitors, and mixtures thereof, for use as a drug in subjects in need thereof, for preventing and/or...

Full description

Saved in:
Bibliographic Details
Main Authors ESTAQUIER, Jérôme, CORBEAU, Pierre, GIMENEZ, Sandrine, KUNDURA, Lucy
Format Patent
LanguageEnglish
French
Published 26.01.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention concerns a composition comprising an Angiotensin receptor 1 (AT1) inhibitor and one or more other active compounds selected from the group consisting of antioxidants, caspase inhibitors, and mixtures thereof, for use as a drug in subjects in need thereof, for preventing and/or treating viral infections due to at least one betacoronavirus, in particular for preventing severe forms of viral infections due to betacoronavirus, in particular COVID-19 due to SARS-CoV-2. La présente invention concerne une composition comprenant un inhibiteur de récepteur 1 de l'angiotensine (AT1) et un ou plusieurs autres composés actifs choisis dans le groupe constitué d'antioxydants, d'inhibiteurs de caspase, et de mélanges de ceux-ci, destinée à être utilisée en tant que médicament chez des sujets le nécessitant, afin de prévenir et/ou traiter des infections virales dues à au moins un Betacoronavirus, en particulier pour prévenir des formes graves d'infections virales dues au Betacoronavirus, en particulier la COVID-19 due au SARS-CoV-2.
Bibliography:Application Number: WO2022EP70184